News & Events

CORRECTION: Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results

This is a correction of the announcement from 07:00 am CET March 26, 2020. Reason for the correction: > As of December 31, 2019, the Loss […]

Vivoryon Therapeutics AG Reports Full Year 2019 Financial Results  

Conference call and webcast (in English) at 3:00 pm CET (10:00 am EDT)   HALLE (SAALE)/MUNICH, Germany, 26 March 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY; ISIN: DE007921835), today […]

Vivoryon Therapeutics AG to Publish its Full Year 2019 Results on March 26, 2020

HALLE (SAALE) / MUNICH, Germany, 19 March 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), will publish its Full Year Results for 2019 on Thursday, […]

Vivoryon Therapeutics Announces Update on Phase 2b Alzheimer’s Clinical Trial, VIVIAD

Vivoryon has extended the trial protocol through the inclusion of exploratory parameters and plans to enroll patients in selected study sites in Denmark, Germany and the […]

Vivoryon Therapeutics to Attend Upcoming Investor Conferences

HALLE (SAALE)/MUNICH, Germany, 3 March 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), announced today that its management will be presenting at and attending the […]

Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration

HALLE (SAALE), Germany and Herlev, Denmark, 14 January 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835) and Nordic Bioscience, announced today an agreement to collaborate […]

Vivoryon Therapeutics to Attend 38th Annual J.P. Morgan Healthcare Conference in January 2020

HALLE (SAALE), Germany, 7 January 2020 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), announced today that the company is scheduled to attend the J.P. Morgan […]

Vivoryon Therapeutics is Included in AScX Index

HALLE (SAALE), Germany, 20 December 2019 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY, ISIN DE0007921835), announced today that the company has been included in the AScX index as of […]

Vivoryon Therapeutics Reports Third Quarter 2019

HALLE (SAALE), Germany, 28 November 2019 – Vivoryon Therapeutics AG (Euronext Amsterdam: VVY; ISIN: DE0007921835), announced today its third quarter business update for the period ending September […]